Revision history of "Implementation of an innovative bacteriophage preparation for aquaculture developed as a result of its own R & D work on the way to a significant increase in the Company’s competitiveness" (Q101526)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

7 October 2024

  • curprev 15:1115:11, 7 October 2024DG Regio talk contribs 92,612 bytes −10 Changed label, description and/or aliases in pt
  • curprev 15:1115:11, 7 October 2024DG Regio talk contribs 92,622 bytes −7 Set a claim value: summary (P836): O investimento pressupõe a implementação de resultados próprios de I & D alcançados através da implementação de um projeto de investigação orientado (executado nos anos 2013-2015 no âmbito do PO IG 1.4, financiamento concedido pelo NCBiR a partir de fundos do FEDER para a atividade empresarial de biotecnologia da Proteon Pharmaceuticals S.A.). O projeto é um investimento inicial relacionado com a diversificação da produção, que consiste na aquisição...

7 March 2024

15 January 2024

12 June 2023

24 May 2023

2 March 2023

  • curprev 19:0619:06, 2 March 2023DG Regio talk contribs 89,871 bytes −314 Changed label, description and/or aliases in da, it, sk, es, lv, ga, fi, el, de, fr, cs, bg, sl, sv, et, lt, pt, ro, nl, hr, hu, mt, and other parts

20 October 2022

27 July 2022

  • curprev 10:5310:53, 27 July 2022DG Regio talk contribs 89,370 bytes +57,786 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

18 January 2022

15 January 2022

17 December 2021

7 December 2021

1 December 2021

  • curprev 09:1209:12, 1 December 2021DG Regio talk contribs 18,671 bytes +3,108 Created claim: summary (P836): L’investissement implique la mise en œuvre à l’entreprise de biotechnologie Proteon Pharmaceuticals S.A. des résultats de R & D obtenus grâce à la mise en œuvre d’un projet de recherche ciblé (mis en œuvre en 2013-15 dans le cadre de l’OP IG 1.4, cofinancement accordé par le NCBiR sur des fonds du FEDER). Le projet est un investissement initial lié à la diversification de la production, consistant en l’acquisition d’un certain nombre d’équipemen...
  • curprev 09:1209:12, 1 December 2021DG Regio talk contribs 15,563 bytes +271 Changed label, description and/or aliases in fr: translated_label

29 October 2020

17 October 2020

  • curprev 14:4714:47, 17 October 2020DG Regio talk contribs 15,731 bytes +249 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 14:4714:47, 17 October 2020DG Regio talk contribs 15,482 bytes −230 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 14:4714:47, 17 October 2020DG Regio talk contribs 15,712 bytes +2,743 Created claim: summary (P836): The investment assumes the implementation of own R & D results achieved through the implementation of a targeted research project (implemented in the years 2013-15 under OP IG 1.4, funding granted by the NCBiR from ERDF funds into the biotechnology business activity of Proteon Pharmaceuticals S.A.). The project is an initial investment related to diversification of production, consisting of the acquisition of a number of specialised equipment, w...
  • curprev 14:4714:47, 17 October 2020DG Regio talk contribs 12,969 bytes −2,422 Removed claim: summary (P836): The investment involves the implementation of PROTEON Pharmaceuticals S.A. into the business of PROTEON Pharmaceuticals S.A. with its own R & D results obtained by carrying out a research project of the Special-Purpose Project (implemented in the 2013-15 period within the framework of OP IG 1.4, co-financing awarded by the NNCR from ERDF resources). As a result, the project is an initial investment in diversification of production, consisting...

17 July 2020

22 June 2020

10 June 2020

7 June 2020

26 March 2020

6 March 2020

  • curprev 09:5209:52, 6 March 2020DG Regio talk contribs 13,665 bytes +2,422 Created claim: summary (P836): The investment involves the implementation of PROTEON Pharmaceuticals S.A. into the business of PROTEON Pharmaceuticals S.A. with its own R & D results obtained by carrying out a research project of the Special-Purpose Project (implemented in the 2013-15 period within the framework of OP IG 1.4, co-financing awarded by the NNCR from ERDF resources). As a result, the project is an initial investment in diversification of production, consisting of...

24 February 2020

18 February 2020

31 January 2020

14 January 2020